Showing results (371-380 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|June 16, 2020
Assurance for clinical trial design with normally distributed outcomes: Eliciting uncertainty about variancesZiyad A Alhussain, Jeremy E OakleyPharmaceutical Statistics|June 16, 2020
A Bayesian approach in design and analysis of pediatric cancer clinical trialsJingjing Ye, Gregory Reaman, R Angelo De Claro, et al.Pharmaceutical Statistics|June 12, 2020
Bayesian optimal phase II clinical trial design with time-to-event endpointHeng Zhou, Cong Chen, Linda Sun, et al.Pharmaceutical Statistics|November 30, 2022
Web based resource for Statistical Consultants in the Pharmaceutical IndustryAlan Phillips, Karen SmithPharmaceutical Statistics|June 9, 2022
Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands frameworkMarian Mitroiu, Steven Teerenstra, Katrien Oude Rengerink, et al.Pharmaceutical Statistics|June 29, 2022
Improving early phase oncology clinical trial design: A case studyAlan J Phillips, Timothy P ClarkPharmaceutical Statistics|January 3, 2023
Just say no to data listings!Mercidita Navarro, Nancy Brucken, Aiming Yang, et al.Pharmaceutical Statistics|June 25, 2021
Assessing safety at the end of clinical trials using system organ classes: A case and comparative studyRaymond Carragher, Chris RobertsonPharmaceutical Statistics|June 25, 2021
Identifying treatment effects using trimmed means when data are missing not at randomAlex Ocampo, Heinz Schmidli, Peter Quarg, et al.Pharmaceutical Statistics|May 23, 2022
Optimal unplanned design modification in adaptive two-stage trialsMaximilian Pilz, Carolin Herrmann, Geraldine Rauch, et al.Pageof 119